A Ketogenic Diet and the Treatment of Autism Spectrum Disorder
Open Access
- 11 May 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
Abstract
Autism spectrum disorder (ASD) is characterized by stereotyped behavior and deficits in communication and social interaction. There are no curative treatments for children with ASD. The ketogenic diet (KD) is a high-fat, appropriate-protein, and low-carbohydrate diet that mimics the fasting state of the body and is proven beneficial in drug-resistant epilepsy and some other brain diseases. An increasing number of studies demonstrated that a KD improved autistic behavior, but the underlying mechanisms are not known. We reviewed the neuroprotective role of a KD in ASD, which is likely mediated via improvements in energy metabolism, reductions in antioxidative stress levels, control of neurotransmitters, inhibition of the mammalian target of rapamycin (mTOR) signaling pathway, and modulation of the gut microbiota. A KD is likely a safe and effective treatment for ASD.This publication has 76 references indexed in Scilit:
- Clinical Characteristics of Children with Autism Spectrum Disorder and Co-Occurring EpilepsyPLOS ONE, 2013
- Ketogenic Diet Improves Core Symptoms of Autism in BTBR MicePLOS ONE, 2013
- Gastrointestinal Dysfunction in Autism: Parental Report, Clinical Evaluation, and Associated FactorsAutism Research, 2012
- Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal DisturbancesPLOS ONE, 2011
- Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum DisordersPLOS ONE, 2011
- The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathwayEpilepsia, 2011
- Aberrant NF-KappaB Expression in Autism Spectrum Condition: A Mechanism for NeuroinflammationAmerican Journal of Translational Research, 2011
- The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodiesBrain Research Reviews, 2009
- Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort AnalysisPLOS ONE, 2008
- The Neuropharmacology of the Ketogenic DietPediatric Neurology, 2007